A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Zynex Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 201,150 shares of ZYXI stock, worth $1.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
201,150
Previous 149,650 34.41%
Holding current value
$1.87 Million
Previous $1.63 Million 52.73%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$9.86 - $13.74 $507,789 - $707,610
51,500 Added 34.41%
201,150 $2.49 Million
Q4 2023

Feb 14, 2024

BUY
$7.1 - $10.89 $124,534 - $191,010
17,540 Added 13.28%
149,650 $1.63 Million
Q3 2023

Nov 14, 2023

BUY
$6.95 - $9.89 $918,164 - $1.31 Million
132,110 New
132,110 $1.06 Million

Others Institutions Holding ZYXI

About ZYNEX INC


  • Ticker ZYXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 37,453,400
  • Market Cap $349M
  • Description
  • Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...
More about ZYXI
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.